Inventor · disambiguated record
Peter Nickolaus
Also filed as: NICKOLAUS PETER
30 granted patents·18 pending applications·129 citations·filing 2005–2025
95Inventor score
Files withBOEHRINGER INGELHEIM INT28POUZET PASCALE8NICKOLAUS PETER6DOLLINGER HORST2POUZET PASCALE A J2
Top patents by PatentIndex Score
48 records- 0194US7511045B2Compounds for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2006·Granted Mar 31, 2009·27 cites·19 claims
- 0293US7723341B2Compounds for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2009·Granted May 25, 2010·19 cites·19 claims
- 0391US8114878B26,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseasesPOUZET PASCALE·Filed 2007·Granted Feb 14, 2012·21 cites·27 claims
- 0489US8354531B2Compounds for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2010·Granted Jan 15, 2013·11 cites·16 claims
- 0586US8609670B2Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthmaPOUZET PASCALE A J·Filed 2012·Granted Dec 17, 2013·13 cites·34 claims
- 0683US8486948B2Piperazinodihydrothienopyrimidine derivativesPOUZET PASCALE·Filed 2008·Granted Jul 16, 2013·6 cites·10 claims
- 0782US10745411B2Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthmaBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 18, 2020·1 cites·2 claims
- 0882US8637519B2Heterocycle-substituted piperazino-dihydrothienopyrimidinesPOUZET PASCALE·Filed 2008·Granted Jan 28, 2014·5 cites·14 claims
- 0982US7674788B2Substituted pteridinesBOEHRINGER INGELHEIM INT·Filed 2007·Granted Mar 9, 2010·5 cites·8 claims
- 1081US9802954B2Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthmaBOEHRINGER INGELHEIM INT·Filed 2013·Granted Oct 31, 2017·2 cites·21 claims
- 1181US7550472B2Substituted pteridines for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jun 23, 2009·5 cites·12 claims
- 1280US12233068B2Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)BOEHRINGER INGELHEIM INT·Filed 2023·Granted Feb 25, 2025·0 cites·6 claims
- 1380US8754073B2Substituted piperazino-dihydrothienopyrimidinesPOUZET PASCALE·Filed 2008·Granted Jun 17, 2014·5 cites·34 claims
- 1479US9161927B2Drug combinations containing PDE4 inhibitors and NSAIDsNICKOLAUS PETER·Filed 2010·Granted Oct 20, 2015·7 cites·28 claims
- 1575US11813266B2Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)BOEHRINGER INGELHEIM INT·Filed 2022·Granted Nov 14, 2023·0 cites·7 claims
- 1674US2025025466A1New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseasesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1774US2025017934A1New therapeutic combinations for the treatment of Progressive Fibrosing interstitial lung diseasesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1872US7718654B2Substituted pteridines for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Granted May 18, 2010·1 cites·7 claims
- 1969US2023181590A1New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseasesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2069US2023190754A1Therapeutic combinations for the treatment of Progressive Fibrosing interstitial lung diseasesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2168US11406638B2Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)BOEHRINGER INGELHEIM INT·Filed 2018·Granted Aug 9, 2022·0 cites·10 claims
- 2267US2025241919A1Combination of active agents for the treatment of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)BOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 2366US8592400B2Drug combinations containing PDE4 inhibitors and NSAIDsNICKOLAUS PETER·Filed 2010·Granted Nov 26, 2013·1 cites·22 claims
- 2462US2024142467A1Use of Biomarkers in the Treatment of Fibrotic Conditions with a PDE4B-inhibitorBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2559US7648988B2Substituted pteridines for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2008·Granted Jan 19, 2010·0 cites·6 claims
- 2659US2018072754A1Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthmaBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2756US8822474B26,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseasesPOUZET PASCALE·Filed 2013·Granted Sep 2, 2014·0 cites·36 claims
- 2854US9150586B2Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthmaPOUZET PASCALE A J·Filed 2012·Granted Oct 6, 2015·0 cites·3 claims
- 2953US7723381B2Compounds for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2006·Granted May 25, 2010·0 cites·10 claims
- 3053US2007015749A1Use of Substituted Pteridines for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 3152US9115142B2Heterocycle-substituted piperazino-dihydrothienopyrimidinesPOUZET PASCALE·Filed 2013·Granted Aug 25, 2015·0 cites·14 claims
- 3252US8604039B2Dihydrothienopyrimidines for the treatment of inflammatory diseasesPOUZET PASCALE·Filed 2012·Granted Dec 10, 2013·0 cites·24 claims
- 3352US2014350035A1Combinations of medicaments, containing pde4-inhibitors and ep4-receptor- antagonistsNICKOLAUS PETER·Filed 2014·Application pending·0 cites
- 3451US9090626B2Piperazino-dihydrothienopyrimidine derivativesPOUZET PASCALE·Filed 2013·Granted Jul 28, 2015·0 cites·9 claims
- 3551US2006116370A1Substituted pteridines for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 3650US8759326B2Drug combinations containing PDE4 inhibitors and NSAIDsNICKOLAUS PETER·Filed 2013·Granted Jun 24, 2014·0 cites·25 claims
- 3750US2005165010A1Use of substituted pteridines for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 3850US2011028441A1Novel phenyl-substituted piperazino-dihydrothienopyrimidinesBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 3947US2010234347A1Substituted Pteridines substituted with a Four-Membered HeterocycleBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 4046US2014228286A1Specific pde4b-inhibitors for the treatment of diabetes mellitusLUIPPOLD GERD·Filed 2014·Application pending·0 cites
- 4145US7750009B2Substituted pteridines for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jul 6, 2010·0 cites·12 claims
- 4245US2013059866A1Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthmaDOLLINGER HORST·Filed 2012·Application pending·0 cites
- 4345US2006270667A1Novel medicament combinations for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 4444US2013225609A1Combinations of medicaments, containing pde4-inhibitors and ep4-receptor-antagonistsNICKOLAUS PETER·Filed 2011·Application pending·0 cites
- 4542US8173699B2Compounds for the treatment of inflammatory diseasesANDERSKEWITZ RALF·Filed 2010·Granted May 8, 2012·0 cites·20 claims
- 4642US2005159414A1Use of substituted pyrimido[5,4-D]pyrimidines for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 4738US8877756B2Substituted pteridinesDOLLINGER HORST·Filed 2010·Granted Nov 4, 2014·0 cites·3 claims
- 4837US8877758B2Combinations of medicaments, containing PDE4-inhibitors and EP4-receptor-antagonistsNICKOLAUS PETER·Filed 2011·Granted Nov 4, 2014·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →